Various treatment options of early carcinoma buccal mucosa involving commissure: a tertiary care centre experience of six years
Keywords:Buccal mucosa, Carcinoma, Commissure, T-stage
Background: Carcinoma of the buccal mucosa is the most common cancer of the oral cavity in India and involvement of commissure poses unique challenge in reconstruction after surgery. Aim was to analyse the demographics, presentations and various treatment options of early carcinoma buccal mucosa involving oral commissure.
Methods: A retrospective review from clinical case records at our institution between 2014 and 2019 were analysed. All the cases recruited were analysed based on patient characteristics, clinical presentation, surgical and adjuvant therapy rendered. Statistical analysis was done using SPSS 20 software.
Results: A total of 40 patients of primary carcinoma buccal mucosa with T1 to T3 disease involving commissure were analysed. Median age of presentation was 51 years with male preponderance (24:16). 32 patients were offered surgery as the initial line of management and 8 received definitive radiotherapy. The estimated 5-year survival was around 30%. Two patients with clinically T2 disease were upstaged in the postoperative histopathology to T3 and T4a respectively one due to depth of invasion >10 mm and the other owing to commissural skin involvement detected only in the final HPE.
Conclusions: Early carcinoma of the buccal mucosa clinically extending from commissure poses unique challenges in choosing treatment modalities. In view of the location of the tumour it poses a small chance of upstaging of early disease in the final histopathology.
Globocan India 2018. Population fact sheets. Available at http://www.gco.iarc.fr/today/data/ factsheets/populations/356-india-fact-sheets.pdf. Accessed on 12 July 2020.
Torre LA, Bray F, Siegel RL, Ferlay J, Tieulent LJ, Jemal A, et al. Global cancer statistics, 2012. Cancer J Clin. 2015;65:87-108.
Incidence, distribution, trends in incidence rates and projections of burden of cancer. In: three-year report of population based cancer registries 2012-2014. Bengaluru; 2016.Available at https:// www. ncdirindia.org/NCRP/all_ncrp_reports/pbcr_report_2012_2014/all_content/pdf_printed_version/preliminary_pages_printed.pdf. Accessed on 10 July 2020.
An assessment of the burden and care of cancer patients. In: consolidated report of hospital based cancer registries 2012-2014. Bengaluru; 2016. Available at https:// ncdirindia. org/ncrp/ Annual_Reports.aspx. Accessed 0n 12 August 2020.
Srivastava V, Kaur T, Sucharita V. Consences document for managment of buccal mucosa cancer. New Delhi: Indian Council of Medical Reserch; 2014. Available at https:// main. icmr. nic.in/ sites/default/files/guidelines/Buccal%20Mucosa%20Cancer%20final%20pdf%209.6.14.pdf. Accessed 0n 12 August 2020.
Agrawal M, Pandey S, Jain S, Maitin S. Oral cancer awareness of the general public in Gorakhpur city, India. Asian Pac J Cancer Prev. 2012;13:5195-9.
Singhania V, Jayade BV, Anehosur V, Gopalkrishnan K, Kumar N. Carcinoma of buccal mucosa: a site specific clinical audit. Indian J Cancer. 2015;52:605-10.
Sayed SI, Sharma S, Rane P, Vaishampayan S, Talole S, Chaturvedi P, et al. Can metastatic lymph node ratio (LNR) predict survival in oral cavity cancer patients? J Surg Oncol. 2013;108:256-63.
Singh AD, Essen CF. Buccal mucosa cancer in South India. Etiologic and clinical aspects. Am J Roentgenol Radium Ther Nucl Med. 1966;96:6-14.
Thiagarajan S, Nair S, Nair D, Chaturvedi P, Kane SV, Agarwal JP, et al. Predictors of prognosis for squamous cell carcinoma of oral tongue. J Surg Oncol. 2014;109:639-44.
Urist MM, O’Brien CJ, Soong SJ, Visscher DW, Maddox WA. Squamous cell carcinoma of the buccal mucosa: analysis of prognostic factors. Am J Surg. 1987;154:411-4.